Melqart Asset Management (Uk) LTD Argenx Se Transaction History
Melqart Asset Management (Uk) LTD
- $1.18 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding ARGX
# of Institutions
371Shares Held
31.4MCall Options Held
303KPut Options Held
429K-
Price T Rowe Associates Inc Baltimore, MD5.6MShares$3.06 Billion0.29% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$1.92 Billion2.39% of portfolio
-
Janus Henderson Group PLC London, X02.47MShares$1.35 Billion0.58% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.92MShares$1.05 Billion0.52% of portfolio
-
Capital World Investors Los Angeles, CA1.51MShares$827 Million0.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $30.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...